Immatics N.V. (IMTX)
NASDAQ: IMTX · IEX Real-Time Price · USD
-0.05 (-0.49%)
At close: Apr 19, 2024, 4:00 PM
-0.10 (-0.98%)
After-hours: Apr 19, 2024, 5:07 PM EDT

Immatics Revenue

In the year 2023, Immatics had annual revenue of $60.00M, a decrease of -67.37%. Revenue in the quarter ending December 31, 2023 was $17.69M, a -55.83% decrease year-over-year.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
1.05B USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.


Fiscal Year End Revenue Change Growth
Dec 31, 202360.00M-123.87M-67.37%
Dec 31, 2022183.86M144.36M365.44%
Dec 31, 202139.50M1.39M3.65%
Dec 31, 202038.11M17.38M83.86%
Dec 31, 201920.73M16.40M378.37%
Dec 31, 20184.33M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Maravai LifeSciences Holdings 288.95M
MannKind 198.96M
Mirum Pharmaceuticals 186.37M
Vir Biotechnology 86.18M
Arcutis Biotherapeutics 59.61M
Silence Therapeutics 32.12M
Liquidia 17.49M
Revenue Rankings